Country focus: China & APAC’s growing medical needs bring opportunities and challenges
pharmaphorum
JUNE 8, 2021
At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. Chemotherapy still accounted for 72.6% About the author.
Let's personalize your content